Stock Scorecard
Stock Summary for Eton Pharmaceuticals Inc (ETON) - $17.28 as of 8/29/2025 3:21:22 PM EST
Total Score
5 out of 30
Safety Score
30 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ETON
Positive Quarterly and Annual earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the Annual earnings growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ETON
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ETON
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ETON
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for ETON (30 out of 100)
Stock Price Rating (Max of 10) | 6 |
Historical Stock Price Rating (Max of 10) | 3 |
Stock Price Trend (Max of 10) | 10 |
Book Value (Max of 10) | 1 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 3 |
Analyst Strong Buy Ratings (Max of 5) | 3 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 0 |
Trading Volume (Max of 10) | 4 |
Price to Earnings (Max of 10) | 0 |
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for ETON
Financial Details for ETON
Company Overview |
|
---|---|
Ticker | ETON |
Company Name | Eton Pharmaceuticals Inc |
Country | USA |
Description | Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases. The company is headquartered in Deer Park, Illinois. |
Sector Name | LIFE SCIENCES |
Industry Name | PHARMACEUTICAL PREPARATIONS |
Most Recent Quarter | 6/30/2025 |
Next Earnings Date | 11/12/2025 |
Stock Price History |
|
Last Day Price | 17.28 |
Price 4 Years Ago | 4.29 |
Last Day Price Updated | 8/29/2025 3:21:22 PM EST |
Last Day Volume | 160,315 |
Average Daily Volume | 344,660 |
52-Week High | 21.48 |
52-Week Low | 4.47 |
Last Price to 52 Week Low | 286.58% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 40.47 |
Sector PE | 60.89 |
5-Year Average PE | -136.77 |
Free Cash Flow Ratio | 18.19 |
Industry Free Cash Flow Ratio | 15.46 |
Sector Free Cash Flow Ratio | 30.76 |
Current Ratio Most Recent Quarter | 1.77 |
Total Cash Per Share | 0.95 |
Book Value Per Share Most Recent Quarter | 0.89 |
Price to Book Ratio | 19.34 |
Industry Price to Book Ratio | 28.68 |
Sector Price to Book Ratio | 26.74 |
Price to Sales Ratio Twelve Trailing Months | 7.96 |
Industry Price to Sales Ratio Twelve Trailing Months | 25.19 |
Sector Price to Sales Ratio Twelve Trailing Months | 13.32 |
Analyst Buy Ratings | 2 |
Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
Total Shares Outstanding | 26,817,500 |
Market Capitalization | 463,406,400 |
Institutional Ownership | 62.48% |
Dividends |
|
Ex-Dividend Date | N/A |
Previous Dividend Amount | 0.0000 |
Current Dividend Amount | 0.0000 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | -12.60% |
Annual Earnings Growth | -308.44% |
Reported EPS 12 Trailing Months | -0.15 |
Reported EPS Past Year | -0.03 |
Reported EPS Prior Year | -0.15 |
Net Income Twelve Trailing Months | -4,128,000 |
Net Income Past Year | -3,823,000 |
Net Income Prior Year | -936,000 |
Quarterly Revenue Growth YOY | 108.60% |
5-Year Revenue Growth | 109.83% |
Operating Margin Twelve Trailing Months | -1.42% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 25,379,000 |
Total Cash Past Year | 14,936,000 |
Total Cash Prior Year | 21,388,000 |
Net Cash Position Most Recent Quarter | -2,030,000 |
Net Cash Position Past Year | -14,875,000 |
Long Term Debt Past Year | 29,811,000 |
Long Term Debt Prior Year | 0 |
Total Debt Most Recent Quarter | 27,409,000 |
Equity to Debt Ratio Past Year | 0.45 |
Equity to Debt Ratio Most Recent Quarter | 0.47 |
Total Stockholder Equity Past Year | 24,428,000 |
Total Stockholder Equity Prior Year | 15,477,000 |
Total Stockholder Equity Most Recent Quarter | 23,961,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | 2,236,000 |
Free Cash Flow Per Share Twelve Trailing Months | 0.08 |
Free Cash Flow Past Year | 943,000 |
Free Cash Flow Prior Year | 6,040,000 |
Options |
|
Put/Call Ratio | 0.10 |
Has Options | Options Chain |
Liquidity Rating | None |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.55 |
MACD Signal | 0.48 |
20-Day Bollinger Lower Band | 12.54 |
20-Day Bollinger Middle Band | 16.15 |
20-Day Bollinger Upper Band | 19.75 |
Beta | 1.14 |
RSI | 64.27 |
50-Day SMA | 13.57 |
150-Day SMA | 7.00 |
200-Day SMA | 6.13 |
System |
|
Modified | 8/29/2025 11:07:13 PM EST |